Inhibition of Borna disease virus replication by ribavirin

Journal of Virology

Volumn 73, Issue 9, 1999, Pages 7903-7906

  Jordan, Ingo ^a   Briese, Thomas ^a   Averett, Devron R ^b   Lipkin, W Ian ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Valeant Pharmaceuticals International   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GUANOSINE DERIVATIVE; RIBAVIRIN;

ANTIVIRAL ACTIVITY; ARTICLE; BORNA DISEASE VIRUS; GLIA CELL; HUMAN; HUMAN CELL; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; VIRUS INHIBITION; VIRUS REPLICATION;

EID: 0032838131     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.73.9.7903-7906.1999     Document Type: Article

References (48)

1. Bautista, J. R., G. J. Schwartz, J. C. De La Torre, T. H. Moran, and K. M. Carbone. 1994. Early and persistent abnormalities in rats with neonatally acquired Borna disease virus infection. Brain Res. Bull. 34:31-40.
2. Bode, L., D. E. Dietrich, R. Stoyloff, H. M. Emrich, and H. Ludwig. 1997. Amantadine and human Borna disease virus in vitro and in vivo in an infected patient with bipolar depression. Lancet 349:178-179.
3. Bode, L., R. Durrwald, and H. Ludwig. 1994. Borna virus infections in cattle associated with fatal neurological disease. Vet. Rec. 135:283-284.
4. Briese, T., J. C. de la Torre, A. Lewis, H. Ludwig, and W. I. Lipkin. 1992. Borna disease virus, a negative-strand RNA virus, transcribes in the nucleus of infected cells. Proc. Natl. Acad. Sci. USA 89:11486-11489.
5. Caplazi, P., A. Waldvogel, L. Stitz, U. Braun, and F. Ehrensperger. 1994. Borna disease in naturally infected cattle. J. Comp. Pathol. 111:65-72.
6. Cubitt, B., and J. C. de la Torre. 1997. Amantadine does not have antiviral activity against Borna disease virus. Arch. Virol. 142:2035-2042.
7. Cubitt, B., and J. C. de la Torre. 1994. Borna disease virus (BDV), a nonsegmented RNA virus, replicates in the nuclei of infected cells where infectious BDV ribonucleoproteins are present. J. Virol. 68:1371-1381.
8. Davis, G. L., R. Esteban-Mur, V. Rustgi, J. Hoefs, S. C. Gordon, C. Trepo, M. L. Shiffman, S. Zeuzem, A. Craxi, M. H. Ling, and J. Albrecht. 1998. Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. N. Engl. J. Med. 339:1493-1499.
9. Dittrich, W., L. Bode, H. Ludwig, M. Kao, and K. Schneider, 1989. Learning deficiencies in Borna disease virus-infected but clinically healthy rats. Biol. Psychiatry 26:818-828.
10. Eriksson, B., E. Helgstrand, N. G. Johansson, A. Larsson, A. Misiorny, J. O. Noren, L. Philipson, K. Stenberg, G. Stening, S. Stridh, and B. Oberg. 1977. Inhibition of influenza virus ribonucleic acid polymerase by ribavirin triphosphate. Antimicrob. Agents Chemother. 11:946-951.
11. Gonzalez-Dunia, D., B. Cubitt, and J. C. de la Torre, 1998. Mechanism of Borna disease virus entry into cells. J. Virol. 72:783-788.
12. Goswami, B. B., E. Borek, O. K. Sharma, J. Fujitaki, and R. A. Smith. 1979. The broad spectrum antiviral agent ribavirin inhibits capping of mRNA. Biochem. Biophys. Res. Commun. 89:830-836.
13. Grabner, A., S. Herzog, A. Hafner, and P. Schmidt. 1998. BDV infections of horses in Germany: clinical and epidemiological aspects. Presented at the Second International Bornavirus Meeting, Freiburg, Germany.
14. Hagiwara, K., S. Kawamoto, H. Takahashi, Y. Nakamura, T. Nakaya, T. Hiramune, C. Ishihara, and K. Ikuta. 1997. High prevalence of Borna disease virus infection in healthy sheep in Japan. Clin. Diagn. Lab. Immunol. 4:339-344.
15. Hall, C. B., J. T. McBride, E. E. Walsh, D. M. Bell, C. L. Gala, S. Hildreth, L. G. Ten Eyck, and W. J. Hall. 1983. Aerosolized ribavirin treatment of infants with respiratory syncytial viral infection. A randomized double-blind study. N. Engl. J. Med. 308:1443-1447.
16. Hallensleben, W., M. Zocher, and P. Staeheli. 1997. Borna disease virus is not sensitive to amantadine. Arch. Virol. 142:2043-2048.
17. Hatalski, C. G., W. F. Hickey, and W. I. Lipkin. 1998. Evolution of the immune response in the central nervous system following infection with Borna disease virus. J. Neuroimmunol. 90:137-142.
18. Hatalski, C. G., A. J. Lewis, and W. I. Lipkin. 1997. Borna disease. Emerg. Infect. Dis. 3:129-135.
19. Herzog, S., and R. Rott. 1980. Replication of Borna disease virus in cell cultures. Med. Microbiol. Immunol. 168:153-158.
20. Hultgren, C., D. R. Milich, O. Weiland, and M. Sallberg. 1998. The antiviral compound ribavirin modulates the T helper (Th) 1/Th2 subset balance in hepatitis B and C virus-specific immune responses. J. Gen. Virol. 79:2381-2391.
21. Kao, M., A. N. Hamir, C. E. Rupprecht, Z. F. Fu, V. Shankar, H. Koprowski, and B. Dietzschold. 1993. Detection of antibodies against Borna disease virus in sera and cerebrospinal fluid of horses in the USA. Vet. Rec. 132: 241-244.
22. Khakoo, S., P. Glue, L. Grellier, B. Wells, A. Bell, C. Dash, I. Murray-Lyon, D. Lypnyj, B. Flannery, K. Walters, and G. M. Dusheiko. 1998. Ribavirin and interferon alfa-2b in chronic hepatitis C: assessment of possible pharmacokinetic and pharmacodynamic interactions. Br. J. Clin. Pharmacol. 46:563-570.
23. Lewis, A. J., J. L. Whitton, C. G. Hatalski, H. Weissenböck, and W. I. Lipkin. 1999. Effect of immune priming on Borna disease. J. Virol. 73:2541-2546.
24. Lipkin, W. I., G. H. Travis, K. M. Carbone, and M. C. Wilson. 1990. Isolation and characterization of Borna disease agent cDNA clones. Proc. Natl. Acad. Sci. USA 87:4184-4188.
25. Liu, M. F., Q. Ning, M. Pope, T. Mosmann, J. Leibowitz, J. W. Ding, L. S. Fung, O. Rotstein, R. Gorczynski, and G. A. Levy. 1998. Resistance of naive mice to murine hepatitis virus strain 3 requires development of a Th1, but not a Th2, response, whereas pre-existing antibody partially protects against primary infection. Adv. Exp. Med. Biol. 440:415-423.
26. Lundgren, A. L., G. Czech, L. Bode, and H. Ludwig. 1993. Natural Borna disease in domestic animals other than horses and sheep. Zentbl. Vetmed. 40:298-303.
27. Malkinson, M., Y. Weisman, S. Perl, and E. Ashash. 1995. A Borna-like disease of ostriches in Israel. Curr. Top. Microbiol. Immunol. 190:31-38.
28. McHutchison, J. G., S. C. Gordon, E. R. Schiff, M. L. Shiffman, W. M. Lee, V. K. Rustgi, Z. D. Goodman, M. H. Ling, S. Cort, and J. K. Albrecht. 1998. Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. N. Engl. J. Med. 339:1485-1492.
29. Metzler, A., F. Ehrensperger, and R. Wyler. 1978. Natural Borna virus infection in rabbits. Zentbl. Vetmed. 25:161-164.
30. Mizutani, T., H. Inagaki, K. Araki, H. Kariwa, J. Arikawa, and I. Takashima. 1998. Inhibition of Borna disease virus replication by ribavirin in persistently infected cells. Arch. Virol. 143:2039-2044.
31. Nakamura, Y., S. Asahi, T. Nakaya, M. K. Bahmani, S. Saitoh, K. Yasui, H. Mayama, K. Hagiwara, C. Ishihara, and K. Ikuta. 1996. Demonstration of Borna disease virus RNA in peripheral blood mononuclear cells derived from domestic cats in Japan. J. Clin. Microbiol. 34:188-191.
32. Nakamura, Y., M. Kishi, T. Nakaya, S. Asahi, H. Tanaka, H. Sentui, K. Ikeda, and K. Ikuta. 1995. Demonstration of Borna disease virus RNA in peripheral blood mononuclear cells from healthy horses in Japan. Vaccine 13:1076-1079.
33. Narayan, O., S. Herzog, K. Frese, H. Scheefers, and R. Rott. 1983. Behavioral disease in rats caused by immunopathological responses to persistent Borna virus in the brain. Science 220:1401-1403.
34. Ning, Q., D. Brown, J. Parodo, M. Cattral, R. Gorczynski, E. Cole, L. Fung, J. W. Ding, M. F. Liu, O. Rotstein, M. J. Phillips, and G. Levy. 1998. Ribavirin inhibits viral-induced macrophage production of TNF, IL-1, the procoagulant fg12 prothrombinase and preserves Th1 cytokine production but inhibits Th2 cytokine response. J. Immunol. 169:3487-3493.
35. Pauli, G., J. Grunmach, and H. Ludwig. 1984. Focus-immunoassay for Borna disease virus-specific antigens. Zentbl. Vetmed. 31:552-557.
36. Prusiner, P., and M Sundaralingam. 1973. A new class of synthetic nucleoside analogues with broad-spectrum antiviral properties. Nat. New Biol. 244:116-118.
37. Richt, J. A., S. Herzog, K. Haberzettl, and R. Rott. 1993. Demonstration of Borna disease virus-specific RNA in secretions of naturally infected horses by the polymerase chain reaction. Med. Microbiol. Immunol. 182:293-304.
38. Rott, R., and H. Becht 1995. Natural and experimental Borna disease in animals. Curr. Top. Microbiol. Immunol. 190:17-30.
39. Schneemann, A., P. A. Schneider, R. A. Lamb, and W. I. Lipkin. 1995. The remarkable coding strategy of Borna disease virus: a new member of the nonsegmented negative strand RNA viruses. Virology 210:1-8.
40. + T cells and perform mRNA. J. Virol. 71:2400-2407.
41. Sprankel, H., K. Richarz, H. Ludwig, and R. Rott. 1978. Behavior alterations in tree shrews (Tupaia glis, Diard 1820) induced by Borna disease virus. Med. Microbiol. Immunol. 165:1-18.
42. Stitz, L., O. Planz, and T. Bilzer. 1998. Lack of antiviral effect of amantadine in Borna disease virus infection. Med. Microbiol. Immunol. 186:195-200.
43. Streeter, D. G., J. T. Witkowski, G. P. Khare, R. W. Sidwell, R. J. Bauer, R. K. Robins, and L. N. Simon. 1973. Mechanism of action of 1-β-D-ribofuranosyl-1,2,4-triazole-3-carboxamide (Virazole), a new broad-spectrum antiviral agent. Proc. Natl. Acad. Sci. USA 70:1174-1178.
44. Taber, L. H., V. Knight, B. E. Gilbert, H. W. McClung, S. Z. Wilson, H. J. Norton, J. M. Thurson, W. H. Gordon, R. L. Atmar, and W. R. Schlaudt. 1983. Ribavirin aerosol treatment of bronchiolitis associated with respiratory syncytial virus infection in infants. Pediatrics 72:513-618.
45. Tam, R. C., B. Pai, J. Bard, C. Lim, D. R. Averett, U. Phan, and T. Milocanovic. Ribavirin polarizes human T cell responses towards a type 1 cytokine profile, J. Hepatol., in press.
46. Weissenbock, H., N. Nowotny, P. Caplazi, J. Kolodziejek, and F. Ehrensperger. 1998. Borna disease in a dog with lethal meningoencephalitis. J. Clin. Microbiol. 36:2127-2130.
47. Wray, S. K., B. E. Gilbert, and V. Knight. 1985. Effect of ribavirin triphosphate on primer generation and elongation during influenza virus transcription in vitro. Antiviral Res. 5:39-48.
48. Zwick, W., O. Seifried, and J. Witte. 1929. Weitere Beiträge zur Erforschung der Bornaschen Krankheit des Pferdes. Arch. Wissensch. Prakt. Tierheilk. 59:511-545.